Dr. Reddy's Laboratories Ltd. closed 14.39% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's Laboratories Ltd. closed 14.67% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Barclays analyst Balaji Prasad maintained a Buy rating on Dr Reddy’s Laboratories (RDY – Research Report) today and set a price target of ...

Indian shares opened on a sluggish note Monday amid fresh tariff and inflation jitters after a measure of U.S. inflation expectations ...

An announcement from Dr Reddy’s Laboratories ( ($RDY) ) is now available. On February 4, 2025, Dr. Reddy’s Laboratories announced its ...

Dr Reddy’s Laboratories ( ($RDY) ) has shared an update. On February 4, 2025, Dr. Reddy’s Laboratories announced its participation in an investor ...

Dr. Reddy's Laboratories DRREDDY RDY has delivered a set of financial results. For the third quarter (Q3FY25) and the nine months (9MFY25) ending December 31, 2024, the company showcased robust ...

Dr. Reddy’s Laboratories has received an order directing the company to pay more than ₹184 crore penalty under the CGST Act 2017. The authority has passed the order on the contention that the ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

Pharmaceutical major Dr Reddy's Laboratories is slated to release its October-December earnings report on January 23. Marking a shift from previous quarters of solid growth, the company's net ...